Navigation Links
Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
Date:2/11/2008

uccessfully develop compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's anticipated operating results, financial condition, liquidity and capital resources, Pharmacopeia's expectations concerning the legal protections afforded by U.S. and international patent law, Pharmacopeia's ability to pursue the development of new compounds and other business matters without infringing the patent rights of others, additional competition, and changes in economic conditions.

Further information about these and other relevant risks and uncertainties may be found in Pharmacopeia's Reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Pharmacopeia urges you to carefully review and consider the disclosures found in its filings which are available in the SEC EDGAR database at http://www.sec.gov and from Pharmacopeia at http://www.pharmacopeia.com. All forward-looking statements in this press release and oral statements made with respect to information contained in this press release are qualified entirely by the cautionary statements included in this press release and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by such forward-looking statements. These forward-looking statements speak only as of the date of this press release. Pharmacopeia undertakes no obligation to (and expressly disclaims any such obligation to) publicly update or revise the statements made herein or the risk factors that may relate thereto whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
2. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Announces Third Quarter 2007 Financial Results
4. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
5. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
6. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
7. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
10. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
11. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015  Merrimack ... that it will present preclinical and clinical ... the 2015 American Association for Cancer Research ... 2015 at the Pennsylvania Convention Center in Philadelphia. The presentations describe ... and nanoliposomal technology platforms, as well as ...
(Date:3/26/2015)... 26. März 2015 Finesse Solutions ... sich speziell an Innovatoren, Visionäre und Führungskräfte ... Die zweitägige Konferenz für geladene Gäste findet ... Hyatt Regency in Downtown San ... werden führende Akteure der Biowissenschaften die Zukunft ...
(Date:3/26/2015)... Calif. , March 26, 2015 ... Care Management (CCM) Physician, Patient and Pharmacy Portals, ... Modular EHR certification, which designates that the software ... the Stage 1 and Stage 2 Meaningful Use ... American Recovery and Reinvestment Act (ARRA). SPAC CCM ...
Breaking Medicine Technology:Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Finesse Solutions kündigt Cellworld 2015 an 2SPAC International's Chronic Care Management Physician, Patient and Pharmacy Portals Achieve ONC HIT 2014 Edition Modular EHR Certification from ICSA Labs 2SPAC International's Chronic Care Management Physician, Patient and Pharmacy Portals Achieve ONC HIT 2014 Edition Modular EHR Certification from ICSA Labs 3
... 17 Emdeon (NYSE: EM ), a leading provider ... it will participate in the Piper Jaffray Annual Health Care Conference ... York. , The "fireside chat", featuring Tracy Bahl, executive chairman, will ... A live audio webcast will be available in the Investors ...
... , NEW YORK, Nov. 17 WebMD Health Corp. (Nasdaq: ... participate at the 2009 Citi Investment Research Small and Mid Cap ... , Investors, analysts and the general public are invited to ... Internet. The broadcast can be accessed at www.wbmd.com ...
Cached Medicine Technology:
(Date:3/26/2015)... (PRWEB) March 26, 2015 Visiting ... celebrate their 18th annual gala fundraiser, Lighting the Way, ... 6:30 p.m. at The Madison Hotel in Morristown, NJ. ... live entertainment by renowned musician Rio Clemente, delightful cuisine, ... Pat and Dave Hertzel. Additionally, two prestigious awards will ...
(Date:3/26/2015)... 26, 2015 The Life Support ... to Hyperbaric Medicine” course, which is accredited by ... and the National Board of Diving & Hyperbaric ... course 4 times a year at several of ... tri-state region; registration is available on-line at: ...
(Date:3/26/2015)... 2015 On March 5, 2015, Portland ... out for the season with a torn Achilles tendon ... Trail Blazers were competing against Dallas, and was confirmed ... Izzy Silva, M.D., who has treated many professional athletes, ... it could be prevented. , "Part of the ...
(Date:3/26/2015)... NY (PRWEB) March 26, 2015 Volunteers ... raise awareness of Parkinson’s disease and funds to support ... to Ease the Burden – Find the Cure. ... and will take place in more than 20 locations ... Island, New Jersey, San Antonio, Minnesota, Seattle, St. Louis, ...
(Date:3/26/2015)... CRN International took the podium this week at ... achievement of jobseekers from five statewide locations as part ... , The program, called Platform to Employment and being ... the Connecticut Department of Labor, takes active steps to ... them at appropriate companies. CRN, a 40-year-old radio marketing ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2Health News:CRN International Shows Support For Groundbreaking Connecticut Program To Aid The Unemployed 2
... business response to global economic and social challengesNEW YORK, April ... aimed at creating new partnerships with governments, NGOs and small ... on Creating Shared Value in New York ... and the Mission of ...
... Inc. (OTC Bulletin Board: PLCSF) announced today that it expects ... the first quarter ended March 31, 2009 before the market ... host a conference call to discuss those results at 11:00 ... joined via telephone by dialing (866) 825-1708 or (617) 213-8060 ...
... 27 Cornerstone Therapeutics Inc. (NasdaqCM: CRTX), a specialty ... for respiratory disorders, today announced that it will host ... May 7, 2009, to discuss its financial results for ... also provide an update on the Company,s strategy, operations ...
... TERI, Inc., a national leader ... with autism and other developmental disabilities, today announced ... Quality Plans(TM) for families and caregivers of people ... the TERI-led International Association for Life Quality ( ...
... Group at Frost & Sullivan is pleased ... the Pharmaceutical CRM Market to be held on Tuesday, ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )2008 has ushered in a variety of ... is adopting a cautious approach, delaying and re-evaluating technology ...
... to highlight advances for chronic condition; third FDA-approved drug to come ... ... Each new treatment that becomes available is a step forward for ... National Fibromyalgia Association (NFA), which is observing Fibromyalgia Awareness ...
Cached Medicine News:Health News:Nestle Launches Major Initiatives in Nutrition, Water and Rural Development 2Health News:Nestle Launches Major Initiatives in Nutrition, Water and Rural Development 3Health News:Nestle Launches Major Initiatives in Nutrition, Water and Rural Development 4Health News:Cornerstone Therapeutics to Host First Quarter 2009 Conference Call 2Health News:Cornerstone Therapeutics to Host First Quarter 2009 Conference Call 3Health News:Cornerstone Therapeutics to Host First Quarter 2009 Conference Call 4Health News:TERI Offers Comprehensive Life Quality Plans to Families, Caregivers of People with Developmental Disabilities 2Health News:Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities? 2Health News:Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities? 3Health News:Treatment Options Increase For Millions with Fibromyalgia 2Health News:Treatment Options Increase For Millions with Fibromyalgia 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: